Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04336020 · ClinicalTrials.gov registry record

The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study

A clinical trial of Influenza and Virus, sponsored by Scripps Translational Science Institute.

Recruiting
Registry status
100,000
Enrollment target
1
Study location

NCT04336020 is a study of Influenza and Virus that is actively recruiting participants, run by Scripps Translational Science Institute. The registered enrollment target is 100,000 participants, above the 36,163-participant average among 156 other Influenza trials with a reported enrollment target (177% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04336020, a study of Influenza and Virus, is actively recruiting participants, sponsored by Scripps Translational Science Institute.

RECRUITING
Registry status
100,000 participants
Enrollment target
1
Study location

Study Summary

Develop an app-based nationwide study of individuals who routinely use a smartwatch or other wearable activity tracker to determine if individualized tracking of changes in heart rate, activity and sleep can provide an early indication of influenza-like illnesses (ILI) and possibly other viral infections.

Conditions Studied

Study Locations (1)

California

  • Scripps Research Translational Institute - San Diego

Trial Details

FieldValue
Enrollment Target 100,000 participants
Start Date 2020-03-24
Est. Completion 2025-04

What the Registry Record Tells You About NCT04336020

The ClinicalTrials.gov registry entry for NCT04336020 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 36,163-participant average among 156 other Influenza trials with a reported enrollment target (177% higher). The listed sponsor is Scripps Translational Science Institute, which has 41 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Influenza appearing as the primary indexed condition, and to 0 interventions.

NCT04336020 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04336020 about?

NCT04336020 is a clinical study titled "The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study". Develop an app-based nationwide study of individuals who routinely use a smartwatch or other wearable activity tracker to determine if individualized tracking of changes in heart rate, activity and sleep can provide an early indication of influenza-like illnesses (ILI) and possibly other viral infec...

What is the current status of trial NCT04336020?

This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2020-03-24. Estimated completion is 2025-04.

What conditions does trial NCT04336020 study?

This clinical trial studies the following conditions: Influenza, Virus.

Who is sponsoring clinical trial NCT04336020?

This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04336020 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Influenza

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.